Abstract
Background: Angiotensin receptors blockers (ARB) and angiotensin conversion enzyme inhibitors (ACEi) are effective for cardiac remodeling, but their clinical interest after isolated aortic valve replacement (AVR) for aortic stenosis (AS) is unclear.